-
Did you know Medicare’s 2025 formulary changes could affect your PH treatments?
If you’re on Medicare and it covers your PH treatments, now’s the perfect time to review your plan to ensure it still includes your PH medications. According to the latest PHA email update, at least one plan is dropping coverage for Adempas, Opsumit, Tracleer, and Ventavis.
But don’t worry; there’s still time, and plenty of resources are available to guide you through this. Remember, Medicare open enrollment ends on December 7th!
Check out the PHA updates and resources for support if your treatments might be affected.
PHA- Medicare 2025 UpdatesHave you reviewed your current Medicare plan? Did this formulary change impact your treatments? Let’s make sure you’re covered!
-
1 Reply
-
@carol-volckmann – here is where I moved your valuable yet frustrating information about this topic.
Carol shares, “I am not sure the information I found belongs in this but I need to get this info out there.
Please look over your 2025 insurance especially if you are on Medicare. Through PH News it stated a number of drugs were not going to be covered by Medicare. The drugs listed were not ones I am on, but I called our Medicare Drug Plan and yes, they were not going to cover what I an on: Remodulin IV, Letaris nir Ambersentin. The cost of these and supplies is over $150,000/year. I quickly changed our plan to perineum plan. If I had not caught this by Dec 7th I would be up the creek without being able to afford my drugs that are keeping me alive.”
Log in to reply.